2014
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.5732/cjc.013.10207
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/24384238
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1000-467X
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_DCA412FE38387
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
A.F. Hottinger et al., « Standards of care and novel approaches in the management of glioblastoma multiforme. », Serveur académique Lausannois, ID : 10.5732/cjc.013.10207
Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor in adults. Standard therapeutic approaches provide modest improvement in the progression-free and overall survival, necessitating the investigation of novel therapies. We review the standard treatment options for GBM and evaluate the results obtained in clinical trials for promising novel approaches, including the inhibition of angiogenesis, targeted approaches against molecular pathways, immunotherapies, and local treatment with low voltage electric fields.